By Abigail Townsend
Date: Thursday 26 Mar 2026
(Sharecast News) - Oxford Biomedica posted a surge in annual revenues on Thursday, but warned it was on track to swing to an interim loss this year before returning to growth in the second half.
| Total Voting Rights | 01-Apr-2026 | 07:00 | RNS |
| 2026 Annual General Meeting notification | 30-Mar-2026 | 15:30 | RNS |
| Preliminary results for the year ended 31 Dec 2025 | 26-Mar-2026 | 07:00 | RNS |
| Admission to Trading | 09-Mar-2026 | 07:53 | RNS |
| Admission to Trading Application | 04-Mar-2026 | 11:45 | RNS |
| Need to know: Opec cuts forecast ... Tesco cuts ... | 16-Aug-2008 | Times |
| Need to know | 10-May-2008 | Times |
| DSG International may be losing its spark | 12-Feb-2008 | Telegraph |
| Oxford BioMedica clinches $690m licensing deal f... | 29-Mar-2007 | The Independent |
| Oxford Biomedica seals €518m deal with Sanofi ov... | 29-Mar-2007 | Times |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 569.00p |
| Change Today | 24.00p |
| % Change | 4.40 % |
| 52 Week High | 913.00 |
| 52 Week Low | 232.50 |
| Volume | 151,999 |
| Shares Issued | 120.90m |
| Market Cap | £687.93m |
| Beta | 0.03 |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 2 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 10 |

| No dividends found |
| Time | Volume / Share Price |
| 16:35 | 4,701 @ 569.00p |
| 16:35 | 15 @ 569.00p |
| 16:35 | 13 @ 569.00p |
| 16:35 | 5 @ 569.00p |
| 16:35 | 6 @ 569.00p |
| Chair | Roch Doliveux |
| CEO | Frank Mathias |
| CFO | Lucinda (Lucy) Crabtree |
You are here: research